Avidity Biosciences (RNA) Stock Price

$29.25 1.6%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    7
  • Fundamental

    7
  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Avidity Biosciences, AI stock picks, stock alerts and much more.

Sign up

RNA AI Stock Analysis

AI stock analysis for RNA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Avidity Biosciences (RNA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Avidity Biosciences (RNA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Avidity Biosciences (RNA), currently trading at $29.25, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About RNA

LSE
  • Avidity Biosciences, Inc.

  • Symbol

    RNA

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    3.5B

Similar Stocks

RNA Alternative Data

Web Traffic

Avidity Biosciences receives an estimated 12754 monthly visitors to aviditybiosciences.com.

  • Web Traffic

    12754

  • Change from Previous Month

    37.5%

  • 3 Month Change

    28.3%

  • YoY Change

    28.3%

Twitter Followers

Avidity Biosciences has 766 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.2% over the last month.

  • Twitter Followers

    766

  • Daily Change

    0.1%

  • 1 Month Change

    1.2%

  • 3 Month Change

    3.7%

  • YoY Change

    3.7%

LinkedIn Followers

27,749 are following Avidity Biosciences on LinkedIn, up by 4.1% over the last month.

  • LinkedIn Followers

    27749

  • Daily Change

    0.1%

  • 1 Month Change

    4.1%

  • 3 Month Change

    15.6%

Job Postings

Avidity Biosciences has an estimated 18 open job postings, which is down -45.5% over the last month.

  • Job Postings

    18

  • Daily Change

    100%

  • 1 Month Change

    45.5%

  • 3 Month Change

    58.1%

  • YoY Change

    58.1%

LinkedIn Employees

According to LinkedIn, Avidity Biosciences has 471 employees, up by 4.7% over the last month.

  • LinkedIn Employees

    471

  • Daily Change

    0%

  • 1 Month Change

    4.7%

  • 3 Month Change

    18.9%

  • YoY Change

    18.9%

Reddit Mentions

Avidity Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Avidity Biosciences is 80 out of 100 (bullish).

  • Business Outlook

    80

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Avidity Biosciences was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

RNA Financials

RNA Key Metrics
  • Total Revenue

    $3M

  • Net Income

    -$102.3M

  • Earnings per Share

    -$0.8

  • Free cash flow

    -$103.8M

  • EBITDA

    -$120.3M

  • EBITDA Ratio

    -40.448

  • Total Assets

    $1.6B

RNA 2-year Revenue & Income
RNA 2-year Free Cash Flow

RNA Technicals

RNA SMA
RNA RSI

FAQ

What's the current price of Avidity Biosciences (RNA) Stock?
The price of an Avidity Biosciences (RNA) share is $29.25.

What's the market cap of Avidity Biosciences?
The current market cap of Avidity Biosciences is 3.5B.

Should I buy or sell RNA?
Avidity Biosciences shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Avidity Biosciences is better viewed as a hold or accumulate position while waiting for further developments.

Is Avidity Biosciences a good investment?
The current analysis of Avidity Biosciences' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Avidity Biosciences' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Avidity Biosciences (RNA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Avidity Biosciences stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Avidity Biosciences (RNA) that investors often compare it to?
Avidity Biosciences (RNA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Avidity Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Avidity Biosciences' stock price to be around $30.9 in 2026. Starting from the current price of $29.25, this represents a 5.7% change in price, indicating a bullish outlook for the stock.

How to buy Avidity Biosciences (RNA) Stock?
Avidity Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Avidity Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.